
FIRST TURN MANAGEMENT, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | MLTX | 263K | $1.88M |
![]() | CYTK | 255K | $14.00M |
![]() | NBIX | 182K | $25.53M |
![]() | HROW | 160K | $7.72M |
![]() | AXSM | 153K | $18.53M |
![]() | ASND | 146K | $29.08M |
![]() | UTHR | 85K | $35.77M |
![]() | NTRA | 81K | $13.02M |
![]() | ARGX | 39K | $28.59M |

MoonLake Immunotherapeutics
MLTX
Shares Held
263K
Value
$1.88M

Cytokinetics, Incorporated
CYTK
Shares Held
255K
Value
$14.00M

Neurocrine Biosciences, Inc.
NBIX
Shares Held
182K
Value
$25.53M

Harrow Health, Inc.
HROW
Shares Held
160K
Value
$7.72M

Axsome Therapeutics, Inc.
AXSM
Shares Held
153K
Value
$18.53M

Ascendis Pharma A/S
ASND
Shares Held
146K
Value
$29.08M

United Therapeutics Corporation
UTHR
Shares Held
85K
Value
$35.77M

Natera, Inc.
NTRA
Shares Held
81K
Value
$13.02M

argenx SE
ARGX
Shares Held
39K
Value
$28.59M
